HIV drug access remains a major challenge despite promising trial results

Promising new drugs to prevent and treat HIV have the potential to transform the response to the disease. But getting these drugs to those who need it most will be critical, says Beatriz Grinsztejn, president of the International AIDS Society.

Immune receptor protein linked to healthy aging and lifespan in mice

Life expectancy and healthy aging in mice can be determined by a protein present in some cells of the immune system, according to a study

November 28, 2023

Combination Therapy Wins FDA Approval for BRAF-Mutated NSCLC

The FDA approved encorafenib (Braftovi) plus binimetinib (Mektovi) for BRAF V600E-mutated metastatic non-small cell lung cancer (NSCLC) as determined by an FDA-approved test, the agency

October 13, 2023

Severe COVID in Kids

It’s easy to think the COVID-19 pandemic is in the rearview mirror, especially for children who are often considered at low risk for severe disease.

October 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.